小梁切除术联合丝裂霉素治疗虹膜角膜内皮综合征继发性青光眼  

Trabeculectomy with mitomycin C and the iridocorneal endothelial Syndrome

作　　者：余克明[1] 叶天才[1] 葛坚[1] 彭大伟[1] 刘杏[1] 

机构地区：[1]中山医科大学中山眼科中心,510060

出　　处：《中国实用眼科杂志》2001年第7期531-532,共2页Chinese Journal of Practical Ophthalmology

摘　　要：目的 :为评价抗青光眼滤过手术联合应用丝裂霉素治疗虹膜角膜内皮 (ICE)综合征继发性青光眼的疗效。方法 :对已确诊为 ICE综合征 ,用局部降眼压药眼压控制不良的 11例继发青光眼病人实施小梁切除手术 ,术中使用丝裂霉素 ,然后对其术后情况进行追踪观察。结果 :经 6 - 5 0个月的随访观察 ,6例 (6只眼 ,5 4.5 % )眼压控制在 2 1mm Hg以下 ,其中 2例须使用局部降眼压药。结论 :小梁切除术联合丝裂霉素能一定程度地提高Objective: To evaluate the effect of trabeculectomy with mitomycin C in the treatment of iridocorneal endothelial (ICE) syndrome Methods: Eleven patients (11 eyes) confirmed as ICE syndrome with uncontrolled intraocular pressure (IOP) underwent trabeculectomy and received mitomycin C in the operation. Clinical data of these cases were analyzed. Results: After 6-50 mouths of follow-up, six eyes (6/11, 54.5%) had intraocular pressure less than or equal to 21mmHg. Four of the six successful eyes were controlled without anti-glaucoma drugs, the other two eyes with one or two kinds of anti-glaucoma drops. Conclusions: Trabeculectomy with mitomycin C could improve the success rate of surgery in secondary glaucoma with ICE syndrome in some extend.

关 键 词：小梁切除术 丝裂霉素 ICE综合征 继发性青光眼 虹膜角膜内皮综合征 

分 类 号：R773.1[医药卫生—眼科] R775.3[医药卫生—临床医学]